Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day
Go back to Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day| (NASDAQ: DFTX) | Delayed: 36.18 -0.49 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.67 | 52 Week High | $ | |||
| Open | $36.42 | 52 Week Low | $ | |||
| Day High | $39.13 | P/E | N/A | |||
| Day Low | $35.25 | EPS | $ | |||
| Volume | 5,640,440 | |||||

